This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William H. McCarthy, AM, MEd, FRACS; John F. Thompson, FRACS, FACS; Roger F. Uren, FRACP, DDU

Arch Surg. 1995;130(6):659-660.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The pioneering work of Morton and colleagues¹ has clearly identified the value of lymphatic mapping in identifying sentinel nodes in patients with melanoma. Their work has been subsequently validated in other centers,^2,3 enabling surgeons, after appropriate training, to correctly identify sentinel nodes in up to 96% of patients with melanoma. Morton et al have also shown that the use of a hand-held gamma detector facilitates identification of the sentinel node. A major international randomized trial of lymphatic mapping and selective sentinel lymphadenectomy is now in progress, and as with any new and unproven technique, it would be inappropriate to recommend its use outside a clinical trial setting until there is proof of its efficacy and reliability.

The article by Krag et al is of considerable interest, but a number of statements are made that may mislead rather than clarify the sentinel node approach. It is claimed, for example, . . . [Full Text PDF of this Article]

Author Affiliations
Sydney, New South Wales, Australia

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?